Literature DB >> 22429671

Functional health status of adults with tetralogy of Fallot: matched comparison with healthy siblings.

Rachel Knowles1, Gruschen Veldtman, Edward J Hickey, Timothy Bradley, Aungkana Gengsakul, Gary D Webb, William G Williams, Brian W McCrindle.   

Abstract

BACKGROUND: Survival prospects for adults with repaired tetralogy of Fallot (TOF) are now excellent. Attention should therefore shift to assessing and improving functional health status and quality of life. We aimed to assess late functional health status of adults surviving TOF repair by matched comparison to their healthy siblings.
METHODS: All 1,693 TOF repairs performed at our institution between 1946 and 1990 were reviewed. A matched comparison was undertaken whereby presumed survivors and their healthy sibling were contacted and asked to complete the Ontario Health Survey 1990 and the 36-Item Short Form Health Survey (SF-36) questionnaire.
RESULTS: Both questionnaires were completed by 224 adult survivors and their sibling closest in age. Adults with repaired TOF had lower scores for self-perceived general health status (p < 0.001), were less likely to rate their health as good or excellent (p < 0.001), and had lower SF-36 scores for physical functioning and general health (p = 0.001) than their siblings. However, patients reported similar satisfaction with their lives, similar levels of social participation and support, and were as likely to be in long-term partnerships. Worse physical and mental health scores were associated with older age at surgery and at time of questionnaire completion and recent requirement for noncardiac medication.
CONCLUSIONS: Although reporting lower functional health status then their siblings, quality of life and life satisfaction for adults who underwent surgery for TOF during childhood is comparable to that of their siblings without heart defects. Follow-up of younger adults is required to understand current health outcomes attributable to improvements in the management of TOF.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22429671     DOI: 10.1016/j.athoracsur.2011.09.056

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Implementation of Quality-of-Life Assessment Increases Referrals for Intervention in Patients with Tetralogy of Fallot.

Authors:  Alisa Siebrasse; Sydney Allen; Julie Lavoie; Janessa Snippen; David Saudek
Journal:  Pediatr Cardiol       Date:  2019-09-05       Impact factor: 1.655

2.  Quality of Life is Diminished in Patients with Tetralogy of Fallot with Mild Residual Disease: A Comparison of Tetralogy of Fallot and Isolated Valvar Pulmonary Stenosis.

Authors:  Shivani M Bhatt; Elizabeth Goldmuntz; Amy Cassedy; Bradley S Marino; Laura Mercer-Rosa
Journal:  Pediatr Cardiol       Date:  2017-08-31       Impact factor: 1.655

3.  Health-related quality of life in congenital heart disease surgery patients in Pakistan: protocol for a mixed-methods study.

Authors:  Laila Akbar Ladak; Babar Sultan Hasan; Janice Gullick; Khadija Awais; Ahmed Abdullah; Robyn Gallagher
Journal:  BMJ Open       Date:  2017-10-30       Impact factor: 2.692

4.  Factors associated with health-related quality of life among adults with tetralogy of Fallot.

Authors:  Anette Sandtröm; Camilla Sandberg; Daniel Rinnström; Gunnar Engström; Mikael Dellborg; Ulf Thilén; Peder Sörensson; Niels-Erik Nielsen; Christina Christersson; Bengt Johansson
Journal:  Open Heart       Date:  2019-02-27

5.  Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers.

Authors:  Bruno Neuner; Sylvia von Mackensen; Susanne Holzhauer; Stephanie Funk; Robert Klamroth; Karin Kurnik; Anne Krümpel; Susan Halimeh; Sarah Reinke; Michael Frühwald; Ulrike Nowak-Göttl
Journal:  Biomed Res Int       Date:  2016-05-15       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.